Immunotherapy with Bet v 1 derived contiguous overlapping peptides: results of a phase I/IIa clinical trial in birch pollen allergic volunteers

被引：0
|
作者：
Spertini, F. [1 ]
Perrin, Y. [1 ]
Longaretti, Pellaton C. [1 ]
Barbier, N. [1 ]
Thierry, A. [1 ]
Audran, R. [1 ]
Charlon, V [2 ]
Reymond, C. [2 ]
机构：
[1] CHU Vaudois, Div Immunol & Allergy, Lausanne, Switzerland
[2] Anergis SA, Epalinges, Switzerland
来源：
ALLERGY | 2010年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
8
引用
收藏
页码：4 / 4
页数：1
相关论文
共 38 条
  • [21] Specific immunotherapy with recombinant birch pollen allergen rBet v 1-FV is clinically efficacious-results of a phase III study
    Kettner, J.
    Meyer, H.
    Narkus, A.
    Cromwell, O.
    Jost, K.
    ALLERGY, 2007, 62 : 33 - 33
  • [22] Different polarization of Th responses by monocyte-derived dendritic cells (MoDCs) of birch pollen allergic and non-atopic donors pulsed with Bet v 1 and homologous food allergens
    Smole, U.
    Balazs, N.
    Hoffmann-Sommergruber, K.
    Ferreira, F.
    Wallner, M.
    Wagner, S.
    Breiteneder, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 81 - 82
  • [23] Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice
    Winkler, B
    Baier, K
    Wagner, S
    Repa, A
    Eichler, HG
    Scheiner, O
    Kraft, D
    Wiedermann, U
    CLINICAL AND EXPERIMENTAL ALLERGY, 2002, 32 (01): : 30 - 36
  • [24] Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies
    Moebs, Christian
    Ipsen, Henrik
    Mayer, Lea
    Slotosch, Caroline
    Petersen, Arnd
    Wurtzen, Peter A.
    Hertl, Michael
    Pfuetzner, Wolfgang
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 130 (05) : 1108 - +
  • [25] A phase I/IIa clinical trial of immunotherapy for elderly patients with acute myeloid leukaemia using dendritic cells co-pulsed with WT1 peptide and zoledronate
    Kitawaki, Toshio
    Kadowaki, Norimitsu
    Fukunaga, Keiko
    Kasai, Yasunari
    Maekawa, Taira
    Ohmori, Katsuyuki
    Kondo, Takashige
    Maekawa, Ryuji
    Takahara, Masashi
    Nieda, Mie
    Kuzushima, Kiyotaka
    Ishikawa, Takayuki
    Uchiyama, Takashi
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (06) : 796 - 799
  • [26] Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial
    de la Portilla, F.
    Alba, F.
    Garcia-Olmo, D.
    Herrerias, J. M.
    Gonzalez, F. X.
    Galindo, A.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2013, 28 (03) : 313 - 323
  • [27] Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn’s disease: results from a multicenter phase I/IIa clinical trial
    F. de la Portilla
    F. Alba
    D. García-Olmo
    J. M. Herrerías
    F. X. González
    A. Galindo
    International Journal of Colorectal Disease, 2013, 28 : 313 - 323
  • [28] Dendritic Cell-based Immunotherapy Pulsed With Wilms Tumor 1 Peptide and Mucin 1 as an Adjuvant Therapy for Pancreatic Ductal Adenocarcinoma After Curative Resection: A Phase I/IIa Clinical Trial
    Nagai, Kazuhiro
    Adachi, Tomohiko
    Harada, Hiroshi
    Eguchi, Susumu
    Sugiyama, Haruo
    Miyazaki, Yasushi
    ANTICANCER RESEARCH, 2020, 40 (10) : 5765 - 5776
  • [29] Persistence of Elevated Anti-Bet v 1 IgG4 Prior and during the Second Pollen Season after Allert Ultra-Fast Immunotherapy; Results from a Phase IIb Study Follow up
    Reymond, Christophe
    Boand, Valerie
    Duc, Samantha
    Kettner, Alexander
    Della Corte, Gilles
    Spertini, Francois
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB143 - AB143
  • [30] A Phase I Clinical Trial of CD1c (BDCA-1)+ Dendritic Cells Pulsed With HLA-A*0201 Peptides for Immunotherapy of Metastatic Hormone Refractory Prostate Cancer
    Prue, Rebecca L.
    Vari, Frank
    Radford, Kristen J.
    Tong, Hui
    Hardy, Melinda Y.
    D'Rozario, Rachael
    Waterhouse, Nigel J.
    Rossetti, Tony
    Coleman, Robert
    Tracey, Christopher
    Goossen, Hans
    Gounder, Vinay
    Crosbie, Georgina
    Hancock, Sonia
    Diaz-Guilas, Stephanie
    Mainwaring, Paul
    Swindle, Peter
    Hart, Derek N. J.
    JOURNAL OF IMMUNOTHERAPY, 2015, 38 (02) : 71 - 76
1234